National Heart, Lung, and Blood Institute; Notice of Meeting of the Sickle Cell Disease Advisory Committee

[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)]
[Notices]
[Page 19736]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10439]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting of 
the Sickle Cell Disease Advisory Committee

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Sickle Cell Disease Advisory Committee, National Heart, 
Lung, and Blood Institute, June 8, 1998. The meeting will be held at 
the National Institutes of Health, Rockledge II, Conference Room 9104, 
6701 Rockledge Drive, Bethesda, Maryland 20892.
    The entire meeting will be open to the public from 9:00 a.m. to 
adjournment, to discuss recommendations on the implementation and 
evaluation of the Sickle Cell Disease Program. Attendance by the public 
will be limited to space available.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations should 
contact the Executive Secretary in advance of the meeting.
    Dr. Clarice D. Reid, Executive Secretary, Sickle Cell Disease 
Advisory Committee, Division of Blood Diseases and Resources NHLBI, Two 
Rockledge Center, Suite 10160, 6701 Rockledge Drive, Bethesda, Maryland 
20892 (301) 435-0080, will furnish substantive program information, a 
summary of the meeting, and a roster of the committee members.

(Catalog of Federal Domestic Assistance Program No. 93.839, Blood 
Diseases and Resources Research, National Institutes of Health)

    Dated: April 14, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-10439 Filed 4-20-98; 8:45 am]
BILLING CODE 4140-01-M